Therapeutics for Eliminating Hepatitis B Virus cccDNA (R21/R33 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save this grant

Deadline: Feb 14, 2023 (Full proposal)

Grant amount: Up to US $300,000

Fields of work: Diseases & Conditions Infectious & Parasitic Diseases

Applicant type: Government Entity, Nonprofit, For-Profit Business, Indigenous Group

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

The purpose of this Funding Opportunity Announcement is to invite applications aimed at discovery of new antivirals that result in the elimination or suppression of HBV ccc DNA from infected cells.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed October 05, 2022 and last updated October 05, 2022